iCoreConnect Inc. (NASDAQ:ICCT) Sees Significant Decrease in Short Interest

iCoreConnect Inc. (NASDAQ:ICCT) was the target of a significant decrease in short interest during the month of June. As of June 15th, there was short interest totalling 251,900 shares, a decrease of 9.9% from the May 31st total of 279,500 shares. Approximately 3.0% of the company’s stock are short sold. Based on an average daily volume of 370,000 shares, the days-to-cover ratio is currently 0.7 days.

Institutional Trading of iCoreConnect

A hedge fund recently bought a new stake in iCoreConnect stock. Sapient Capital LLC acquired a new stake in iCoreConnect Inc. (NASDAQ:ICCT) during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 31,256 shares of the company’s stock, valued at approximately $39,000. Sapient Capital LLC owned 0.35% of iCoreConnect at the end of the most recent reporting period. Hedge funds and other institutional investors own 13.42% of the company’s stock.

iCoreConnect Trading Down 3.3 %

NASDAQ ICCT traded down $0.03 on Wednesday, hitting $0.87. 3,074 shares of the stock were exchanged, compared to its average volume of 343,420. The company has a debt-to-equity ratio of 0.19, a quick ratio of 0.11 and a current ratio of 0.11. The business’s fifty day moving average is $1.02 and its 200 day moving average is $1.27. iCoreConnect has a 52 week low of $0.12 and a 52 week high of $20.70.

iCoreConnect (NASDAQ:ICCT) last posted its quarterly earnings results on Wednesday, May 15th. The company reported ($0.51) earnings per share (EPS) for the quarter. The business had revenue of $2.72 million for the quarter.

About iCoreConnect

iCoreConnect Inc, a cloud-based software and technology company, provides Health Insurance Portability and Accountability Act (HIPAA) compliant cloud-based software as a service (SaaS) in the United States. The company's products include iCoreRx, a HIPAA compliant electronic prescription software; iCorePDMP, a solution that checks the patient's Prescription Drug Monitoring Program (PDMP) history before prescribing controlled substances; iCoreVerify and iCoreVerify+, a HIPAA compliant SaaS solution that automatically retrieves a patients insurance eligibility breakdown to verify their benefits in advance of their appointment and on-demand; iCoreHuddle and iCoreHuddle+, a tool to instantly reveal the revenue potential of each patient; and iCoreCodeGenius, a medical coding reference SaaS solution.